Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Antibiotics Not Helpful for Cough Due to Lower Respiratory Tract Infection
THURSDAY, April 25, 2024 -- Antibiotics have no measurable impact on the severity or duration of cough due to acute lower respiratory tract infection (LRTI)...
Hypertensive Disorders of Pregnancy Raise Risk for Postpartum Mortality for One Year
THURSDAY, April 25, 2024 -- Hypertensive disorders of pregnancy (HDPs) are strong risk factors for pregnancy-associated mortality due to cardiovascular...
Occurrence of Low-Birth-Weight Babies Heightened in Active-Duty Servicewomen
THURSDAY, April 25, 2024 -- Active-duty servicewomen in the United States appear to have an increased occurrence of low-birth-weight babies compared with...
Differences ID'd in Tau Burden in Down Syndrome, Alzheimer Disease
THURSDAY, April 25, 2024 -- The spatial distribution, timing, and magnitude of tau burden differs for people with Down syndrome and those with...
AI Model Reduces False Positives in Screening Mammograms
THURSDAY, April 25, 2024 -- A semiautonomous breast cancer screening system reduces false positives with screening mammograms, according to a study published...
U.S. Births Declined in 2023, Marking End to Post-Pandemic Rise
THURSDAY, April 25, 2024 -- The short post-pandemic uptick in U.S. births may be over, with 2023 numbers showing a decline in births. According to provisional...
FDA Approves New Antibiotic Against UTIs, Pivya (pivmecillinam)
THURSDAY, April 25, 2024 -- As many patients already know, urinary tract infections (UTIs) can recur despite the use of antibiotics. So, it's welcome news...
New School Lunch Rules Target Added Sugars, Salt
THURSDAY, April 25, 2024 -- School lunches will soon contain less added sugars and salt under new nutrition standards announced by the U.S. Department of...
Could Heartburn Meds Raise Your Migraine Risk?
THURSDAY, April 24, 2024 -- People taking heartburn meds have a higher risk of migraines and other types of severe headaches, a new study warns. All classes...
Watchdog Group Says U.S. Food Recalls Rose Again Last Year
THURSDAY, April 25, 2024 -- U.S. recalls of foods for salmonella, foreign objects or undeclared allergens are rampant nowadays and the highest they've been...
FDA Approves Pivya (pivmecillinam) for the Treatment of Uncomplicated Urinary Tract Infections
April 24, 2024 -- Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated...
FDA Grants Accelerated Approval for Ojemda (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma
BRISBANE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a...
Abeona Therapeutics Provides Regulatory Update on Pz-cel
CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...
FDA Approves Anktiva (nogapendekin alfa inbakicept-pmln) Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
CULVER CITY, Calif., April 22, 2024 -- ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration...
U.S. FDA Approves Subcutaneous Administration of Takeda’s Entyvio (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
OSAKA, Japan April 19, 2024 and CAMBRIDGE, Massachusetts, April 18, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug...
FDA Approves Lumisight (pegulicianine) Optical Imaging Agent to Illuminate Residual Breast Cancer Post-Lumpectomy
NEWTON, Mass.--(BUSINESS WIRE) April 18, 2024 --Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging...
Supernus Provides Regulatory Update for SPN-830
ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
Stealth Biotherapeutics Announces FDA Acceptance of New Drug Application for Elamipretide for the Treatment of Barth Syndrome
NEEDHAM, Mass., April 8, 2024 /PRNewswire/ — Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and...
Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer
DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a...
Datopotamab Deruxtecan Biologics License Application Accepted in the US for Patients with Previously Treated Metastatic HR-Positive, HER2-Negative Breast Cancer
2 April 2024 -- AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...
Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testing
FORT MYERS, Fla., April 25, 2024. Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist and hematologist Ernesto Bustinza-Linares...
Gene-Based Therapy Restores Cellular Development and Function in Brain Cells From People With Timothy Syndrome
April 24, 2024 -- In a proof-of-concept study, researchers demonstrated the effectiveness of a potential new therapy for Timothy syndrome, an often...
Lykos Therapeutics Announces Completion of European Phase 2 Study for MDMA-Assisted Therapy for PTSD
SAN JOSE, Calif., April 24, 2024. Lykos Therapeutics (formerly MAPS Public Benefit Corporation) ("Lykos"), a company dedicated to transforming mental...
Endevica Bio drug candidate shows success in weight loss in new study
NORTHBROOK, Ill., April 23, 2024 - Endevica Bio, a company developing first-in-class peptide drug candidates, announced its novel weight-loss treatment was...
FDA Approves Clinical Trial for GFH925 Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
SHANGHAI, April 19, 2024. GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.